Loading live market data…

ARS Pharmaceuticals, Inc.

NASDAQ:SPRY

$7.61 USD

-$0.13 (-1.68%)

Volume
1.91M
Average Volume
1.8M
Market Capitalization
$755.7M
P/E Ratio
-3.79
Dividend Yield
0.00%
Price Target
$25.50
Year High
$18.63
Year Low
$6.66
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.94

SPRY Estimated and Actual Revenue by Quarter

SPRY Estimated and Actual EPS by Quarter

SPRY Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 -108.41M -81.65M -96.1M -108.43M -81.67M -96.12M
2028-09-30 1 -155.73M -117.29M -138.06M -155.77M -117.32M -138.09M
2028-06-30 1 -104.83M -78.95M -92.93M -104.85M -78.97M -92.95M
2028-03-31 1 -66.68M -50.22M -59.11M -66.69M -50.23M -59.12M
2027-12-31 1 -61.18M -46.08M -54.23M -61.19M -46.09M -54.25M
2027-09-30 2 -80.88M -60.91M -71.7M -80.9M -60.93M -71.71M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 12.46M 18.07M 15.49M 33.32B 44.23B 39.21B
2028-09-30 1 33.74M 48.92M 41.94M 47.86B 63.55B 56.33B
2028-06-30 1 -1.08M -742.89K -923.46K 32.22B 42.78B 37.92B
2028-03-31 1 -36.33M -25.06M -31.15M 20.49B 27.21B 24.12B
2027-12-31 1 -20.84M -14.37M -17.87M 18.8B 24.96B 22.13B
2027-09-30 2 -5.8M -4M -4.97M 24.86B 33B 29.26B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 104.51M 138.76M 123.01M 1 0.1255 0.18196 0.156
2028-09-30 1 150.14M 199.34M 176.72M 1 0.33981 0.4927 0.4224
2028-06-30 1 101.06M 134.19M 118.96M 1 -0.01084786 -0.00748152 -0.0093
2028-03-31 1 64.28M 85.35M 75.66M 1 -0.36591 -0.25236 -0.3137
2027-12-31 1 58.98M 78.31M 69.42M 1 -0.2099 -0.14476 -0.17995
2027-09-30 2 77.97M 103.53M 91.78M 1 -0.05843846 -0.04030366 -0.0501